Literature DB >> 11275260

Isolation and structure-functional characterization of phage display library-derived mimotopes of noxiustoxin, a neurotoxin of the scorpion Centruroides noxius Hoffmann.

T Gazarian1, B Selisko, P Hérion, K Gazarian.   

Abstract

Noxiustoxin (NTX) is a short-chain toxin from the venom of the scorpion Centruroides noxius Hoffmann, whose molecular structure and physiological effects have been characterized in detail, whereas the antigenic properties of this and other K(+) channel-blocking toxins are poorly studied. A monoclonal antibody against NTX, BNTX18, able to inhibit the binding of NTX to rat brain synaptosomes, was used in the present study for selecting immunoreactive peptides, mimotopes, from a 12mer and a 7mer phage library. The peptides were characterized immunologically and used for mapping the epitope on NTX. In total, 75 phage clones carrying 43 different peptides were analyzed of which 42 clones carrying 17 different peptides, twelve 12mer and five 7mer peptides, presented a single consensus motif: Leu(Ile, Val)-Tyr(Phe, Trp, Leu)-Gly-Met(Ala). All but three of the peptides containing this motif were reactive with selected mAb BNTX18 in a dot-blot assay of which eight were clearly positive in ELISA and exhibited in competition-inhibition assay the antibody binding specificity of the NTX epitope recognized by BNTX18. The two most reactive mimotopes injected into mice showed the ability to induce antibodies reacting with NTX, thus, to mimic the epitope of NTX antigenically. Sequence comparison and the analysis of the three-dimensional structure of NTX led to the proposal that residues Glu19-Leu20-Tyr21-Gly22 and the hydrophobic part of the side chain of Lys18 form the C-terminal part of the epitope. Due to the frequent presence of residues Pro, Leu, Thr, Arg, and Gln in the N-terminal part of the mimotopes, corresponding homologous residues in the N-terminal proximity of the partial epitope may be part of an additional more hydrophilic epitope element.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11275260     DOI: 10.1016/s0161-5890(00)00091-2

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  4 in total

1.  Bioluminescent detection of zearalenone using recombinant peptidomimetic Gaussia luciferase fusion protein.

Authors:  Riikka Peltomaa; Sabrina Fikacek; Elena Benito-Peña; Rodrigo Barderas; Trajen Head; Sapna Deo; Sylvia Daunert; María C Moreno-Bondi
Journal:  Mikrochim Acta       Date:  2020-09-04       Impact factor: 5.833

Review 2.  Innovative Immunization Strategies for Antivenom Development.

Authors:  Erick Bermúdez-Méndez; Albert Fuglsang-Madsen; Sofie Føns; Bruno Lomonte; José María Gutiérrez; Andreas Hougaard Laustsen
Journal:  Toxins (Basel)       Date:  2018-11-02       Impact factor: 4.546

3.  Development of specific nanobodies (VHH) for CD19 immuno-targeting of human B-lymphocytes.

Authors:  Seyed Reza Banihashemi; Ahmad Zavaran Hosseini; Fatemeh Rahbarizadeh; Davoud Ahmadvand
Journal:  Iran J Basic Med Sci       Date:  2018-05       Impact factor: 2.699

4.  Synthetic peptides to produce antivenoms against the Cys-rich toxins of arachnids.

Authors:  Silvia A Camperi; Gerardo Acosta; Gabriela R Barredo; Lucía C Iglesias-García; Cleópatra Alves da Silva Caldeira; María C Martínez-Ceron; Silvana L Giudicessi; Osvaldo Cascone; Fernando Albericio
Journal:  Toxicon X       Date:  2020-05-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.